产NDM耐碳青霉烯酶的肺炎克雷伯杆菌引起的人工瓣膜感染性心内膜炎1例
A Case of Prosthetic Valve Infective Endocarditis Caused by NDM Carbapenemase-Producing Klebsiella pneumoniae
DOI: 10.12677/acm.2026.162539, PDF,   
作者: 沈思佳, 李兰娟*:浙江大学医学院附属第一医院,传染病诊治国家重点实验室,浙江 杭州;魏茹楠:浙江树人学院树兰国际医学院附属树兰杭州医院感染科,全省人工器官与计算医学重点实验室,浙江 杭州
关键词: 感染性心内膜炎人工瓣膜置换多重耐药菌Infective Endocarditis Prosthetic Valve Replacement Multidrug-Resistant Bacteria
摘要: 产新德里金属β-内酰胺酶的肺炎克雷伯菌(New Delhi metallo-β-lactamase-producing Klebsiella pneumoniae, NDM-KP)是肠杆菌科克雷伯菌属中一种对多种抗生素耐药的泛耐药菌株,其感染后临床病死率显著升高。本病例为首例公开报道的NDM-KP引起的早期人工瓣膜感染性心内膜炎(Prosthetic Valve Endocarditis, PVE)成功救治案例。该患者经多次心脏超声检查均未发现典型瓣膜感染征象,最终通过PET-CT确诊。经6周针对性抗感染治疗后,患者临床治愈。本案例旨在提升临床医师对NDM-KP相关PVE的早期识别能力,减少误诊和漏诊风险。
Abstract: New Delhi metallo-β-lactamase-producing Klebsiella pneumoniae (NDM-KP) is a pan-drug-resistant strain within the Enterobacteriaceae family, with significantly elevated clinical mortality rates upon infection. This case represents the first publicly reported instance of NDM-KP-induced early prosthetic valve endocarditis (PVE) successfully treated. The patient underwent multiple transthoracic echocardiographic examinations that initially failed to reveal typical valve infection signs, with final diagnosis confirmed by PET-CT. After six weeks of targeted antibiotic therapy, the patient achieved clinical cure. This case aims to enhance clinicians’ early recognition of NDM-KP-related PVE, thereby reducing risks of misdiagnosis and missed diagnosis.
文章引用:沈思佳, 魏茹楠, 李兰娟. 产NDM耐碳青霉烯酶的肺炎克雷伯杆菌引起的人工瓣膜感染性心内膜炎1例[J]. 临床医学进展, 2026, 16(2): 1508-1513. https://doi.org/10.12677/acm.2026.162539

参考文献

[1] Falcone, M., Tiseo, G., Durante-Mangoni, E., Ravasio, V., Barbaro, F., Ursi, M.P., et al. (2018) Risk Factors and Outcomes of Endocarditis Due to Non-HACEK Gram-Negative Bacilli: Data from the Prospective Multicenter Italian Endocarditis Study Cohort. Antimicrobial Agents and Chemotherapy, 62, e02208-17. [Google Scholar] [CrossRef] [PubMed]
[2] Novais, Â., Ferraz, R.V., Viana, M., da Costa, P.M. and Peixe, L. (2022) NDM-1 Introduction in Portugal through a ST11 KL105 Klebsiella Pneumoniae Widespread in Europe. Antibiotics, 11, Article No. 92. [Google Scholar] [CrossRef] [PubMed]
[3] Patel, S.K., Hassan, S.M.A., Côté, M., Leis, B. and Yanagawa, B. (2024) Current Trends and Challenges in Infective Endocarditis. Current Opinion in Cardiology, 40, 75-84. [Google Scholar] [CrossRef] [PubMed]
[4] Murdoch, D.R., Corey, G.R., Hoen, B., et al. (2009) Clinical Presentation, Etiology, and Outcome of Infective Endocarditis in the 21st Century: The International Collaboration on Endocarditis-Prospective Cohort Study. Archives of Internal Medicine, 169, 463-473. [Google Scholar] [CrossRef] [PubMed]
[5] Iacovelli, A., Spaziante, M., Al Moghazi, S., Giordano, A., Ceccarelli, G. and Venditti, M. (2018) A Challenging Case of Carbapenemase-Producing Klebsiella Pneumoniae Septic Thrombophlebitis and Right Mural Endocarditis Successfully Treated with Ceftazidime/Avibactam. Infection, 46, 721-724. [Google Scholar] [CrossRef] [PubMed]
[6] Benenson, S., Navon-Venezia, S., Carmeli, Y., Adler, A., Strahilevitz, J., Moses, A.E., et al. (2009) Carbapenem-resistant Klebsiella pneumoniae Endocarditis in a Young Adult. International Journal of Infectious Diseases, 13, e295-e298. [Google Scholar] [CrossRef] [PubMed]
[7] Chaari, A., Mnif, B., Chtara, K., Abid, L., Charfeddine, S., Baccouche, N., et al. (2015) Efficacy of Tigecycline-Colistin Combination in the Treatment of Carbapenem-Resistant Klebsiella pneumoniae Endocarditis. Journal of Global Antimicrobial Resistance, 3, 214-216. [Google Scholar] [CrossRef] [PubMed]
[8] Pitsikakis, K., Skandalakis, M., Fragkiadakis, K., Baliou, S. and Ioannou, P. (2024) Infective Endocarditis by Carbapenem-Resistant Gram-Negative Bacteria—A Systematic Review. Germs, 14, 149-161. [Google Scholar] [CrossRef] [PubMed]
[9] Babes, E.E., Bustea, C., Ilias, T.I., Babes, V.V., Luca, S., Luca, C.T., et al. (2023) Multimodality Imaging Diagnosis in Infective Endocarditis. Life, 14, Article No. 54. [Google Scholar] [CrossRef] [PubMed]
[10] Thiravetyan, B., Puchongmart, C., Cruz, D., Rodriguez, C.C. and Soliman, D. (2025) Diagnostic Performance of Prosthetic Heart Valve Infective Endocarditis: A Comparison of Diagnostic Modalities and Proposed Algorithm. The American Journal of Cardiology, 255, 146-154. [Google Scholar] [CrossRef
[11] Roque, A. and Pizzi, M.N. (2025) Infection vs Inflammation in Prosthetic Heart Valves by [18F]FDG-PET/CT: A Practical Tutorial for Accurate Interpretation. Journal of Nuclear Cardiology, 45, Article ID: 102053. [Google Scholar] [CrossRef] [PubMed]
[12] Li, J., Wu, W., Wu, H., Huang, J., Li, Z., Wang, J., et al. (2025) Rapid Emergence, Transmission, and Evolution of KPC and NDM Coproducing Carbapenem-Resistant Klebsiella pneumoniae. Microbiological Research, 293, Article ID: 128049. [Google Scholar] [CrossRef] [PubMed]
[13] Wang, N., Zhan, M., Wang, T., Liu, J., Li, C., Li, B., et al. (2023) Long Term Characteristics of Clinical Distribution and Resistance Trends of Carbapenem-Resistant and Extended-Spectrum Β-Lactamase Klebsiella pneumoniae Infections: 2014-2022. Infection and Drug Resistance, 16, 1279-1295. [Google Scholar] [CrossRef] [PubMed]
[14] Marshall, S., Hujer, A.M., Rojas, L.J., Papp-Wallace, K.M., Humphries, R.M., Spellberg, B., et al. (2017) Can Ceftazidime-Avibactam and Aztreonam Overcome β-Lactam Resistance Conferred by Metallo-β-Lactamases in Enterobacteriaceae? Antimicrobial Agents and Chemotherapy, 61, e02243-16. [Google Scholar] [CrossRef] [PubMed]
[15] Wang, G., Zhang, H., Wu, Q., Xu, J., Qiu, X., Chen, J., et al. (2025) Study on the in Vitro Synergistic Susceptibility and Biofilm Inhibition Mechanism of Ceftazidime-Avibactam Combined with Aztreonam against Carbapenem-Resistant Klebsiella pneumoniae. Frontiers in Microbiology, 16, Article ID: 1542029. [Google Scholar] [CrossRef] [PubMed]
[16] 中国医师协会感染科医师分会, 中华预防医学会医院感染控制分会, 中国医院协会临床微生物实验室专委员会, 等. 高毒力碳青霉烯类耐药肺炎克雷伯菌感染诊治与防控专家共识[J]. 中华临床感染病杂志(中英文), 2025, 18(0): 1-18.
[17] Isler, B., Aslan, A.T., Akova, M., Harris, P. and Paterson, D.L. (2022) Treatment Strategies for OXA-48-Like and NDM Producing Klebsiella pneumoniae Infections. Expert Review of Anti-Infective Therapy, 20, 1389-1400. [Google Scholar] [CrossRef] [PubMed]
[18] del Val, D., Panagides, V., Mestres, C.A., Miró, J.M. and Rodés-Cabau, J. (2023) Infective Endocarditis after Transcatheter Aortic Valve Replacement: JACC State-of-the-Art Review. Journal of the American College of Cardiology, 81, 394-412. [Google Scholar] [CrossRef] [PubMed]
[19] Habib, G., Lancellotti, P., Antunes, M.J., et al. (2015) 2015 ESC Guidelines for the Management of Infective Endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC) Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). European Heart Journal, 36, 3075-3128. [Google Scholar] [CrossRef] [PubMed]
[20] Shirley, M. (2025) Aztreonam-Avibactam: A Review in the Treatment of Serious Bacterial Infections Caused by Aerobic Gram-Negative Organisms. Drugs, 86, 79-91. [Google Scholar] [CrossRef
[21] Carmeli, Y., Cisneros, J.M., Paul, M., Daikos, G.L., Wang, M., Torre-Cisneros, J., et al. (2025) Aztreonam-Avibactam versus Meropenem for the Treatment of Serious Infections Caused by Gram-Negative Bacteria (REVISIT): A Descriptive, Multinational, Open-Label, Phase 3, Randomised Trial. The Lancet Infectious Diseases, 25, 218-230. [Google Scholar] [CrossRef] [PubMed]
[22] Mihos, C.G., Capoulade, R., Yucel, E., Picard, M.H. and Santana, O. (2017) Surgical versus Medical Therapy for Prosthetic Valve Endocarditis: A Meta-Analysis of 32 Studies. The Annals of Thoracic Surgery, 103, 991-1004. [Google Scholar] [CrossRef] [PubMed]
[23] Nappi, F. (2024) Advancements and Challenges in the Management of Prosthetic Valve Endocarditis: A Review. Pathogens, 13, Article No. 1039. [Google Scholar] [CrossRef] [PubMed]
[24] Toyoda, N., Itagaki, S., Egorova, N.N., Tannous, H., Anyanwu, A.C., El-Eshmawi, A., et al. (2017) Real-World Outcomes of Surgery for Native Mitral Valve Endocarditis. The Journal of Thoracic and Cardiovascular Surgery, 154, 1906-1912.e9. [Google Scholar] [CrossRef] [PubMed]
[25] Azelmat, S., Baadi, T., Benaissa, E., Jaafari, A. and Chadli, M. (2024) Infective Endocarditis Caused by Carbapenemase-Producing Klebsiella pneumoniae on a Prosthetic Valve: A Case Report and Review of the Literature. Cureus, 16, e64639. [Google Scholar] [CrossRef] [PubMed]